These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16634565)

  • 1. [Pathogenesis of metabolic syndrome].
    Tobe K; Yamauchi T; Kubota N; Hara K; Ueki K; Kadowaki T
    Seikagaku; 2006 Mar; 78(3):208-20. PubMed ID: 16634565
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization.
    Simons PJ; van den Pangaart PS; Aerts JM; Boon L
    J Endocrinol; 2007 Feb; 192(2):289-99. PubMed ID: 17283229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of obese patients with IGT].
    Yoshida T; Umekawa T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():552-6. PubMed ID: 15779440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Syndrome X].
    Kotake H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():706-11. PubMed ID: 12430306
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes.
    Pan Y; Shu JL; Gu HF; Zhou DC; Liu XL; Qiao QY; Fu SK; Gao FH; Jin HM
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):116-23. PubMed ID: 23313788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to treatment of the patient with metabolic syndrome: lifestyle therapy.
    Stone NJ; Saxon D
    Am J Cardiol; 2005 Aug; 96(4A):15E-21E. PubMed ID: 16098838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Front Horm Res; 2013; 40():40-50. PubMed ID: 24002404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus.
    Hansen E; Hajri T; Abumrad NN
    Surgery; 2006 Jun; 139(6):711-6. PubMed ID: 16782424
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
    Lo J; Bernstein LE; Canavan B; Torriani M; Jackson MB; Ahima RS; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E102-9. PubMed ID: 17374698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective.
    Minehira K; Tappy L
    Eur J Clin Nutr; 2002 Dec; 56(12):7 p following 1262. PubMed ID: 12494312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
    Hajer GR; van Haeften TW; Visseren FL
    Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes.
    Pérez-Matute P; Marti A; Martínez JA; Fernández-Otero MP; Stanhope KL; Havel PJ; Moreno-Aliaga MJ
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):50-8. PubMed ID: 17321040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokines and metabolic syndrome.
    Matsuzawa Y
    Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of insulin resistance].
    Tobe K; Nemoto S; Kadowaki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():114-30. PubMed ID: 15779355
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and treatment of the metabolic syndrome with lifestyle intervention: where do we start?
    Sullivan VK
    J Am Diet Assoc; 2006 May; 106(5):668-71. PubMed ID: 16647323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.